
ab61250 at 1/500 - 1/1000 dilution staining Histone H2B in HeLa cells by Immunofluorescence, in the absence or presence of the immunising peptide.

ab61250 at 1/50 - 1/100 dilution staining Histone H2B in human breast carcinoma by Immunohistochemistry, Paraffin-embedded tissue, in the absence or presence of the immunising peptide.

All lanes : Anti-Histone H2B antibody (ab61250) at 1/500 dilutionLane 1 : COS7 cell extracts treated with TSA (400nM, 24hours)Lane 2 : COS7 cell extracts treated with TSA (400nM, 24hours) with the immunising peptide